We design, organize and initiate late phase clinical trials, clinical outcomes research and health economic evaluation, for the purpose of helping our partners, clients, and government better assess real world evidence, comparative effectiveness, health economic values, unmet medical needs, market dynamics and accessibility, and post-marketing safety of clinical interventions.


Existing Research Platforms: